Lazard Research & Insights
April 20, 2026
Lazard Healthcare Services Leaders Study 2026
Healthcare leaders are entering 2026 with cautious optimism and a sharper focus on execution — even as the imperative to deploy capital remains intense.
Lazard Global Biopharmaceutical Leaders Study 2025
Biopharmaceutical and biotech investors ended the summer of 2025 amid heightened uncertainty and significant financial market pressures.
Lazard Healthcare Services Leaders Study 2025
Lazard Healthcare Services Leaders Study 2025